Stage IIIC Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Gonadorelin (DB00644)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04037254Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate CancerTreatment